Cell Therapy Manufacturing Trends And Advancements Continuing In 2025
By Tyler Menichiello, contributing editor
The demand to increase manufacturing capacity and reduce production times is fueling innovation in cell therapy manufacturing. These innovations are focused across the manufacturing workflow — from improving growth conditions and cell expansion to automating certain processes. In this segment from “Executive Roundtable: Cell Therapy Predictions For 2025 And Beyond,” CEO, co-founder, and president of Ossium Health, Kevin Caldwell; CSO of FibroBiologics, Hamid Khoja, Ph.D.; and president and acting CEO of Triumvira Immunologics, Rob Williamson, reflect on recent advances in cell therapy manufacturing and discuss active areas of innovation.
This website uses cookies to ensure you get the best experience on our website. Learn more